L3MBTL2 Polyclonal Antibody


  • Specification
  • Target Information
  • Related Products
Cat.No.:  EAb-2103
Product Name:  L3MBTL2 Polyclonal Antibody
Antibody Type:  Polyclonal
Immunogen:  This L3MBTL2 antibody was raised against a His-Tagged fusion protein containing amino acids 1-230 of human L3MBTL2.
Host:  Rabbit
Isotype:  Serum
Molecular Weight:  90 kDa
Purification:  None
Appearance:  Liquid
Formulation:  Rabbit serum containing 30% glycerol and 0.035% sodium azide.
Applications:  IP: 10 µl per IP; WB: 1:500 - 1:2,000 dilution^Recommended dilutions/conditions may not be available for all applications. Specific conditions for reactivity should be optimized by the end user.
Species Reactivity:  Human
Storage:  -20°C
Warning:  For Research Use Only! Not For Use in Humans.
Scientific Background:  L3MBTL2 (Lethal (3) malignant brain tumor-like 2 protein) is a putative member of the polycomb group family and is the human homolog of Drosophila Sfmbt, critical for Hox gene silencing. L3MBTL2 contains one FCS-type zinc finger and four MBT (malignant brain tumor) repeats. L3MBTL2 associates with chromatin-remodeling complexes and helps inhibit the expression of proteins that trigger the cells into mitosis. L3MBTL2 is a part of a complex involved in the G0 phase of the cell cycle. This complex contains other proteins such as E2F-6, Max or HP1 gamma, and participates in transcriptional repression.
Product Types
◆ Antibodies
EAb-0070 L3MBTL1 Polyclonal Antibody Inquiry
◆ Extracts & Lysates
EL-0077 Recombinant Human L3MBTL1 Cell Lysate Inquiry
◆ Cell Lines
CL-0097 Human L3MBTL2 Knockout Cell Line 8bp deletion Inquiry
◆ Bioactive Small Molecules
BSM-0244 UNC 1215 Inquiry
BSM-0245 UNC-669 Inquiry
Related Gene / Proteins
L3MBTL1 L3MBTL2 L3MBTL3 L3MBTL4

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.